ClearPoint Neuro (CLPT) Change in Receivables (2011 - 2026)
ClearPoint Neuro (CLPT) posted Change in Receivables of $2.0 million for Q1 2026, up 163.92% sequentially from $765000.0 in Q4 2025, and up 338.65% YoY from $460273.2 in Q1 2025.
ClearPoint Neuro (CLPT) Change in Receivables (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Change in Receivables for 15 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Change in Receivables rose 338.65% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 159.78% YoY) and the FY2025 annual result came in at $268000.0, down 77.78% from the prior year.
- Change in Receivables rose to $2.0 million in Q1 2026 per CLPT's latest filing, from $765000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $2.0 million in Q1 2026 and troughed at -$846000.0 in Q1 2024.
- A 5-year average of $324000.0 and a median of $401000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables surged 489.47% in 2023, then slumped 559.78% in 2024.
- Over 5 years, Change in Receivables stood at -$771000.0 in 2022, then surged by 248.12% to $1.1 million in 2023, then retreated by 8.14% to $1.0 million in 2024, then dropped by 27.07% to $765000.0 in 2025, then soared by 163.92% to $2.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $2.0 million, $765000.0, and -$260000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -90.00 Mn |
| 10 | ClearPoint Neuro | 467.73 Mn | 438.33 Mn | 6.71 Mn | -268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -268,000.00 |
| Jun 30, 2026 | -268,000.00 |
| Mar 31, 2026 | 2.02 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 765,000.00 |
| Dec 31, 2025 | 765,000.00 |
| Sep 30, 2025 | -260,000.00 |
| Sep 30, 2025 | -260,000.00 |
| Jun 30, 2025 | 609,000.00 |
| Jun 30, 2025 | 609,000.00 |
| Mar 31, 2025 | -846,000.00 |
| Mar 31, 2025 | -846,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 602,000.00 |
| Mar 31, 2024 | -846,000.00 |
| Mar 31, 2024 | -846,000.00 |